Study of ABT-751 in Patients With Refractory Hematologic Malignancies [clinicaltrials:NCT00047489]
Study of ABT-751 in Patients With Refractory Hematologic Malignancies [clinicaltrials:NCT00047489]
Bio2RDF identifier
NCT00047489
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00047489
identifiers.org URI
actual enrollment [clinicaltrials_vocabulary:actual-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
ABT-751 is a new antitu ...... 1
will also be studied.
brief title [clinicaltrials_vocabulary:brief-title]
Study of ABT-751 in Patients With Refractory Hematologic Malignancies
completion date [clinicaltrials_vocabulary:completion-date]
2005-01-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The current low cure ra ...... lymerization of microtubules.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2002-10-08T00:00:00Z
intervention [clinicaltrials_vocabulary:intervention]
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2012-02-20T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
link [clinicaltrials_vocabulary:link]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00047489
official title [clinicaltrials_vocabulary:official-title]
A Phase I Study of ABT-751 in Patients With Refractory Hematologic Malignancies
org study id [clinicaltrials_vocabulary:org-study-id]
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2005-01-01T00:00:00Z
responsible party [clinicaltrials_vocabulary:responsible-party]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2002-12-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2012-02-01T00:00:00Z
identifier
clinicaltrials:NCT00047489
title
Study of ABT-751 in Patients With Refractory Hematologic Malignancies
@en
type
label
Study of ABT-751 in Patients W ...... s [clinicaltrials:NCT00047489]
@en